The following Structured Product Label (SPL) was submitted to the FDA by Bm Private Limited for the product Bm Egiolax Plus (NDC 85816-6030). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, otc - purpose, dosage & administration, otc - keep out of reach of children, warnings, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredients (Ref. stand.)
Each tablet contains:
Ingredient Amount Standard
Aloes soco 2X 0.015mg (HPUS)
Belladona 7X 0.0005mg (HPUS)
Bryonia alba 7X 0.0005mg (HPUS)
Cascara sag 3X 0.0000055mg (EHPI)
Hydrastis can 1X 0.005mg (HPUS)
Ipecac 7X 0.0002mg (EHPI)
Phenolphthalein 1X 0.00005mg (EHPI)
Senna 3X 0.01mg (HPUS)
Indications
Help support to relieve the symptoms of constipation, for detail please read the enclosed package (Product information leaflet).
Indications
Help support to relieve the symptoms of constipation, for detail please read the enclosed package (Product information leaflet).
Dosage
Adult: 1 or 2 tablets before going to bed with water, or as needed.
Children: half of the same.
Precautions/storage
Keep away from children and store at cool and dry place.
Precautions/storage
Keep away from children and store at cool and dry place.
Corn Starch, Magnesium stearate, Aerosil-200, Di-Calcium Phosphate, MCC, Lactose Monohydrate
* Please review the disclaimer below.
